Marc Beer is a gentleman who co-founded a new startup company called Renovia Incorporated. He graduated from Miami University with a Bachelor’s degree. Renovia Inc. was founded back in August of 2016 with two other founders, being Ramon Iglesias, MD and Yolanda Lorié. The company was initiated after the first round of funding, Series A, has been completed with venture healthcare funds behind it. Beer is not just the co-founder, but CEO of this new company as well. Co-founder, Marc Beer, while helping with the new company also serves as a member of OvaScience (Nasdaq: OVAS). He provides OVaScience with strategic consulting. Marc Beer is also a member of a cancer foundation group know as Joe Andruzzi Cancer Foundation. Since the opening of Renovia Incorporated, Marc Beer already has planned several new products for a disorder called pelvic floor disorders. He’ll be moving along with each new product the company is planning on producing. With the funds the company has raised, the total comes out to be 42 million dollars altogether. Series B round once it closed, was funded for 32 million dollars. Then the company obtained funds of 10 million dollars in venture debt. These funds will help with Renovia production and research purposes. Though the CEO was asked questions about the pipelines through investments none were answered as of yet.
Renovia Inc., a Boston-based medical-tech, is getting ready to produce 4 different types of therapeutical and diagnostic products for the disorder. The first of many new products approved for Marc Beer’s company was Leva. The approval of the product was announced by the FDA around April of last year. Leva was approximated to help around 250 million women around the world. It was made possible by investors who sole focus is on healthcare and the health of the women. Investors, like The Longwood Fund, invested early on in Renovia beginnings. The group joined in the Series B round, along with observational advisors and ascension ventures from locations, like New York and Missouri. All the funding goes straight to products of the new company, to help with the disorders. Renovia already has four more developing products, these products will go through the tests, before being sent to help millions of women in need. With some tenacity, the new incorporation will be able to produce a new and better Leva product. With innovations from the company and help from the funds, the CEO is hoping that the new technology will inform ways to treat and test the disorder. Effectively, it should help lower the long-term cost that would follow treatment. Marc Beer hopes and aspirations are to better the lives of women everywhere. Learn more: https://people.equilar.com/bio/marc-beer-aegerion-pharmaceuticals-/salary/78453